Literature DB >> 11390825

Renal Transport of Urate in Humans.

Françoise Roch-Ramel1, Barbara Guisan.   

Abstract

The theory of the "four-component model" of urate excretion in humans is reevaluated, considering that a decrease in urate excretion induced by drugs like pyrazinamide or by endogenous compounds like lactate and ketone bodies might be a result of stimulation of urate reabsorption and not, as previously considered, of inhibition of urate secretion.

Entities:  

Year:  1999        PMID： 11390825     DOI： 10.1152/physiologyonline.1999.14.2.80

Source DB:  PubMed          Journal:  News Physiol Sci        ISSN： 0886-1714


  28 in total

Review 1.  Effects of dairy intake on hyperuricemia and gout.

Authors:  Nicola Dalbeth; Kate Palmano
Journal:  Curr Rheumatol Rep       Date:  2011-04       Impact factor: 4.592

2.  Gout, diuretics and the kidney.

Authors:  E Pascual; M Perdiguero
Journal:  Ann Rheum Dis       Date:  2006-08       Impact factor: 19.103

Review 3.  Hyperuricemia and Hypertension: Links and Risks.

Authors:  Douglas J Stewart; Valerie Langlois; Damien Noone
Journal:  Integr Blood Press Control       Date:  2019-12-24

Review 4.  Targeting urate to reduce oxidative stress in Parkinson disease.

Authors:  Grace F Crotty; Alberto Ascherio; Michael A Schwarzschild
Journal:  Exp Neurol       Date:  2017-06-13       Impact factor: 5.330

5.  Developing potent human uric acid transporter 1 (hURAT1) inhibitors.

Authors:  Michael F Wempe; Promsuk Jutabha; Bettina Quade; Timothy J Iwen; Morin M Frick; Ian R Ross; Peter J Rice; Naohiko Anzai; Hitoshi Endou
Journal:  J Med Chem       Date:  2011-03-30       Impact factor: 7.446

6.  Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate.

Authors:  Promsuk Jutabha; Naohiko Anzai; Kenichiro Kitamura; Atsuo Taniguchi; Shuji Kaneko; Kunimasa Yan; Hideomi Yamada; Hidetaka Shimada; Toru Kimura; Tomohisa Katada; Toshiyuki Fukutomi; Kimio Tomita; Wako Urano; Hisashi Yamanaka; George Seki; Toshiro Fujita; Yoshinori Moriyama; Akira Yamada; Shunya Uchida; Michael F Wempe; Hitoshi Endou; Hiroyuki Sakurai
Journal:  J Biol Chem       Date:  2010-09-01       Impact factor: 5.157

7.  Cardiovascular Risks of Probenecid Versus Allopurinol in Older Patients With Gout.

Authors:  Seoyoung C Kim; Tuhina Neogi; Eun Ha Kang; Jun Liu; Rishi J Desai; MaryAnn Zhang; Daniel H Solomon
Journal:  J Am Coll Cardiol       Date:  2018-03-06       Impact factor: 24.094

8.  [Molecular basis of primary renal hyperuricemia : role of the human urate transporter hURAT1].

Authors:  S Unger; A-K Tausche; S Kopprasch; S R Bornstein; M Aringer; J Grässler
Journal:  Z Rheumatol       Date:  2007-11       Impact factor: 1.372

9.  The W258X mutation in SLC22A12 is the predominant cause of Japanese renal hypouricemia.

Authors:  Fusako Komoda; Takashi Sekine; Jun Inatomi; Atsushi Enomoto; Hitoshi Endou; Toshiyuki Ota; Takeshi Matsuyama; Tsutomu Ogata; Masahiro Ikeda; Midori Awazu; Koji Muroya; Isamu Kamimaki; Takashi Igarashi
Journal:  Pediatr Nephrol       Date:  2004-03-31       Impact factor: 3.714

10.  Identification of a novel gene and a common variant associated with uric acid nephrolithiasis in a Sardinian genetic isolate.

Authors:  Fernando Gianfrancesco; Teresa Esposito; Maria Neve Ombra; Paola Forabosco; Giuseppe Maninchedda; Mauro Fattorini; Stefania Casula; Simona Vaccargiu; Giuseppina Casu; Francesco Cardia; Ivo Deiana; Paola Melis; Mario Falchi; Mario Pirastu
Journal:  Am J Hum Genet       Date:  2003-05-09       Impact factor: 11.025
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.